The eXpeRience registry: The 'real-world' effectiveness of omalizumab in allergic asthma

The results from eXpeRience indicate that omalizumab was associated with improvements in outcomes in patients with uncontrolled persistent allergic asthma; these improvements were consistent with the results of clinical trials.